A Study to Evaluate the Safety, Tolerability and Efficacy of AK3280 Cream on Hypertrophic Scar
Clinical trial NCT05434897 · COMPLETED
Trial details
- NCT number
- NCT05434897
- Sponsor
- Shanghai Ark Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-08
- Primary completion
- 2023-07-18
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.